The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells
- Publication type:
- Journal article
- Metadata:
-
- Autoren
- Rashda Abbasi
- Thomas Efferth
- Christine Kuhmann
- Till Opatz
- Xiaojiang Hao
- Odilia Popanda
- Peter Schmezer
- Sammlungen
- metadata
- ISSN
- 0041-008X
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Toxicology and applied pharmacology
- Schlüsselwörter
- 540 Chemie
- 540 Chemistry and allied sciences
- Sprache
- eng
- Paginierung
- Seiten: 302 - 310
- Datum der Veröffentlichung
- 2012
- Herausgeber
- Elsevier
- Herausgeber URL
- http://dx.doi.org/10.1016/j.taap.2012.01.006
- Datum der Datenerfassung
- 2020
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 2020
- Zugang
- Public
- Titel
- The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells
- Ausgabe der Zeitschrift
- 259
Data source: METADATA.UB
- Other metadata sources:
-
- Autoren
- Rashda Abbasi
- Thomas Efferth
- Christine Kuhmann
- Till Opatz
- Xiaojiang Hao
- Odilia Popanda
- Peter Schmezer
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000301892800005&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1016/j.taap.2012.01.006
- eISSN
- 1096-0333
- Externe Identifier
- Clarivate Analytics Document Solution ID: 913QP
- PubMed Identifier: 22280988
- ISSN
- 0041-008X
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- TOXICOLOGY AND APPLIED PHARMACOLOGY
- Schlüsselwörter
- Cancer therapy
- Synthetic lethal
- Traditional Chinese medicine
- XPC
- ERCC6
- CSB
- Paginierung
- 302 - 310
- Datum der Veröffentlichung
- 2012
- Status
- Published
- Titel
- The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells
- Sub types
- Article
- Ausgabe der Zeitschrift
- 259
Data source: Web of Science (Lite)
- Autoren
- Rashda Abbasi
- Thomas Efferth
- Christine Kuhmann
- Till Opatz
- Xiaojiang Hao
- Odilia Popanda
- Peter Schmezer
- DOI
- 10.1016/j.taap.2012.01.006
- ISSN
- 0041-008X
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Toxicology and Applied Pharmacology
- Sprache
- en
- Paginierung
- 302 - 310
- Datum der Veröffentlichung
- 2012
- Status
- Published
- Herausgeber
- Elsevier BV
- Herausgeber URL
- http://dx.doi.org/10.1016/j.taap.2012.01.006
- Datum der Datenerfassung
- 2024
- Titel
- The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells
- Ausgabe der Zeitschrift
- 259
Data source: Crossref
- Abstract
- Targeting synthetic lethality in DNA repair pathways has become a promising anti-cancer strategy. However little is known about such interactions with regard to the nucleotide excision repair (NER) pathway. Therefore, cell lines with a defect in the NER genes ERCC6 or XPC and their normal counterparts were screened with 53 chemically defined phytochemicals isolated from plants used in traditional Chinese medicine for differential cytotoxic effects. The screening revealed 12 drugs that killed NER-deficient cells more efficiently than proficient cells. Five drugs were further analyzed for IC(50) values, effects on cell cycle distribution, and induction of DNA damage. Ascaridol was the most effective compound with a difference of >1000-fold in resistance between normal and NER-deficient cells (IC(50) values for cells with deficiency in ERCC6: 0.15μM, XPC: 0.18μM, and normal cells: >180μM). NER-deficiency combined with ascaridol treatment led to G2/M-phase arrest, an increased percentage of subG1 cells, and a substantially higher DNA damage induction. These results were confirmed in a second set of NER-deficient and -proficient cell lines with isogenic background. Finally, ascaridol was characterized for its ability to generate oxidative DNA damage. The drug led to a dose-dependent increase in intracellular levels of reactive oxygen species at cytotoxic concentrations, but only NER-deficient cells showed a strongly induced amount of 8-oxodG sites. In summary, ascaridol is a cytotoxic and DNA-damaging compound which generates intracellular reactive oxidative intermediates and which selectively affects NER-deficient cells. This could provide a new therapeutic option to treat cancer cells with mutations in NER genes.
- Addresses
- Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
- Autoren
- Rashda Abbasi
- Thomas Efferth
- Thomas Efferth
- Christine Kuhmann
- Till Opatz
- Xiaojiang Hao
- Odilia Popanda
- Peter Schmezer
- DOI
- 10.1016/j.taap.2012.01.006
- eISSN
- 1096-0333
- Externe Identifier
- PubMed Identifier: 22280988
- Open access
- false
- ISSN
- 0041-008X
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Toxicology and applied pharmacology
- Schlüsselwörter
- Cell Line
- Humans
- DNA Damage
- Peroxides
- Reactive Oxygen Species
- Monoterpenes
- Drugs, Chinese Herbal
- Antineoplastic Agents, Phytogenic
- Medicine, Chinese Traditional
- Inhibitory Concentration 50
- DNA Repair
- Dose-Response Relationship, Drug
- M Phase Cell Cycle Checkpoints
- G2 Phase Cell Cycle Checkpoints
- Cyclohexane Monoterpenes
- Sprache
- eng
- Medium
- Print-Electronic
- Online publication date
- 2012
- Paginierung
- 302 - 310
- Datum der Veröffentlichung
- 2012
- Status
- Published
- Datum der Datenerfassung
- 2012
- Titel
- The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells.
- Sub types
- Comparative Study
- Research Support, Non-U.S. Gov't
- Journal Article
- Ausgabe der Zeitschrift
- 259
Data source: Europe PubMed Central
- Abstract
- Targeting synthetic lethality in DNA repair pathways has become a promising anti-cancer strategy. However little is known about such interactions with regard to the nucleotide excision repair (NER) pathway. Therefore, cell lines with a defect in the NER genes ERCC6 or XPC and their normal counterparts were screened with 53 chemically defined phytochemicals isolated from plants used in traditional Chinese medicine for differential cytotoxic effects. The screening revealed 12 drugs that killed NER-deficient cells more efficiently than proficient cells. Five drugs were further analyzed for IC(50) values, effects on cell cycle distribution, and induction of DNA damage. Ascaridol was the most effective compound with a difference of >1000-fold in resistance between normal and NER-deficient cells (IC(50) values for cells with deficiency in ERCC6: 0.15μM, XPC: 0.18μM, and normal cells: >180μM). NER-deficiency combined with ascaridol treatment led to G2/M-phase arrest, an increased percentage of subG1 cells, and a substantially higher DNA damage induction. These results were confirmed in a second set of NER-deficient and -proficient cell lines with isogenic background. Finally, ascaridol was characterized for its ability to generate oxidative DNA damage. The drug led to a dose-dependent increase in intracellular levels of reactive oxygen species at cytotoxic concentrations, but only NER-deficient cells showed a strongly induced amount of 8-oxodG sites. In summary, ascaridol is a cytotoxic and DNA-damaging compound which generates intracellular reactive oxidative intermediates and which selectively affects NER-deficient cells. This could provide a new therapeutic option to treat cancer cells with mutations in NER genes.
- Date of acceptance
- 2012
- Autoren
- Rashda Abbasi
- Thomas Efferth
- Christine Kuhmann
- Till Opatz
- Xiaojiang Hao
- Odilia Popanda
- Peter Schmezer
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/22280988
- DOI
- 10.1016/j.taap.2012.01.006
- eISSN
- 1096-0333
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Toxicol Appl Pharmacol
- Schlüsselwörter
- Antineoplastic Agents, Phytogenic
- Cell Line
- Cyclohexane Monoterpenes
- DNA Damage
- DNA Repair
- Dose-Response Relationship, Drug
- Drugs, Chinese Herbal
- G2 Phase Cell Cycle Checkpoints
- Humans
- Inhibitory Concentration 50
- M Phase Cell Cycle Checkpoints
- Medicine, Chinese Traditional
- Monoterpenes
- Peroxides
- Reactive Oxygen Species
- Sprache
- eng
- Country
- United States
- Paginierung
- 302 - 310
- PII
- S0041-008X(12)00015-4
- Datum der Veröffentlichung
- 2012
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 2012
- Titel
- The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells.
- Sub types
- Comparative Study
- Journal Article
- Research Support, Non-U.S. Gov't
- Ausgabe der Zeitschrift
- 259
Data source: PubMed
- Beziehungen:
- Property of